Carregant...
Zn(II)-curc targets p53 in thyroid cancer cells
TP53 mutation is a common event in many cancers, including thyroid carcinoma. Defective p53 activity promotes cancer resistance to therapies and a more malignant phenotype, acquiring oncogenic functions. Rescuing the function of mutant p53 (mutp53) protein is an attractive anticancer therapeutic str...
Guardat en:
| Publicat a: | Int J Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4583539/ https://ncbi.nlm.nih.gov/pubmed/26314369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2015.3125 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|